Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$6,669,998
in 2 filings, $6.7M under 10b5-1 plans

Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-27 BATE KENNETH Director Option exercise · Stock Option (Right to Buy) −9,470 0
2025-02-27 BATE KENNETH Director Option exercise · Stock Option (Right to Buy) −4,530 5,470
2024-06-25 BATE KENNETH Director Grant or award +714 1,912
2024-06-25 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +1,105 1,105
2024-04-02 BATE KENNETH Director Option exercise 10b5-1 +11,212 $105.08 $1.2M 12,410
2024-04-02 BATE KENNETH Director Sale 10b5-1 −1,217 $243.28 $296K 11,193
2024-04-02 BATE KENNETH Director Sale 10b5-1 −7,048 $244.27 $1.7M 4,145
2024-04-02 BATE KENNETH Director Sale 10b5-1 −2,080 $244.97 $510K 2,065
2024-04-02 BATE KENNETH Director Sale 10b5-1 −567 $246.20 $140K 1,498
2024-04-02 BATE KENNETH Director Sale 10b5-1 −100 $246.88 $25K 1,398
2024-04-02 BATE KENNETH Director Sale 10b5-1 −193 $248.49 $48K 1,205
2024-04-02 BATE KENNETH Director Sale 10b5-1 −7 $249.05 $2K 1,198
2024-04-02 BATE KENNETH Director Option exercise · Stock Option (Right to Buy) 10b5-1 −11,212 0
2024-04-01 BATE KENNETH Director Option exercise 10b5-1 +10,000 $9.45 $95K 11,198
2024-04-01 BATE KENNETH Director Option exercise 10b5-1 +10,000 $100.45 $1.0M 21,198
2024-04-01 BATE KENNETH Director Option exercise 10b5-1 +1,277 $105.08 $134K 22,475
2024-04-01 BATE KENNETH Director Sale 10b5-1 −6,698 $255.62 $1.7M 15,777
2024-04-01 BATE KENNETH Director Sale 10b5-1 −7,411 $256.49 $1.9M 8,366
2024-04-01 BATE KENNETH Director Sale 10b5-1 −2,790 $257.33 $718K 5,576
2024-04-01 BATE KENNETH Director Sale 10b5-1 −2,104 $258.24 $543K 3,472

Page 3 of 4 · 78 trades